Skip to main content
Biotech, Remote
  • Lead the clinical development strategy for oncology programs, ensuring alignment with regulatory, scientific, and commercial objectives.
  • Oversee the design, execution, and analysis of Phase I-III clinical trials, working closely with cross-functional teams.
  • Serve as a key clinical expert in regulatory interactions (FDA, EMA, etc.), contributing to INDs, NDAs, and BLAs.
  • Provide strategic leadership on biomarker-driven trials, immuno-oncology, targeted therapies, or novel oncology treatments.
  • Collaborate with R&D, medical affairs, commercial teams, and external KOLs to drive clinical innovation.
  • Develop and maintain relationships with investigators, regulatory agencies, and external partners.
  • Represent the company at scientific conferences, advisory boards, and industry meetings.
  • MD or MD/PhD, board-certified oncologist required.
  • 10+ years of clinical development experience, with a strong background in oncology drug development in biotech or pharma.
  • Proven track record in leading clinical trials (Phases I-III) and successfully navigating regulatory submissions.
  • Strong knowledge of GCP, ICH guidelines, and regulatory requirements for oncology drug development.
  • Experience working in a biotech environment, with the ability to thrive in a fast-paced, innovative setting.
  • Excellent leadership, communication, and strategic thinking skills.
Accepted file types: doc, docx, pdf, odt, Max. file size: 100 MB.